publication date: Dec. 19, 2010
In this issue:
SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.
Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.
National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.
Paulette Gray named director of NCI Division of Extramural Activities.
Download (PDF 337KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.